Sam Cohen

All read papers (48)

CRISPR-Cas12a target binding unleashes indiscriminate single-stranded DNase activity

Chen JS, Ma E, Harrington LB, Da Costa M, Tian X, Palefsky JM, Doudna JA.

Science · 2018

2.8/5

Nivolumab in patients with advanced hepatocellular carcinoma (CheckMate 040): an open-label, non-comparative, phase 1/2 dose escalation and expansion trial

El-Khoueiry AB, Sangro B, Yau T, Crocenzi TS, Kudo M, Hsu C, Kim TY, Choo SP, Trojan J, Welling TH, Meyer T, Kang YK, Yeo W, Chopra A, Anderson J, Dela Cruz C, Lang L, Neely J, Tang H, Dastani HB, Melero I.

Lancet · 2017

2.0/5

Toward defining the preclinical stages of Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease

Sperling RA, Aisen PS, Beckett LA, Bennett DA, Craft S, Fagan AM, Iwatsubo T, Jack CR, Kaye J, Montine TJ, Park DC, Reiman EM, Rowe CC, Siemers E, Stern Y, Yaffe K, Carrillo MC, Thies B, Morrison-Bogorad M, Wagster MV, Phelps CH.

Alzheimers Dement · 2011

3.8/5

A system of shuttle vectors and yeast host strains designed for efficient manipulation of DNA in Saccharomyces cerevisiae

Sikorski RS, Hieter P.

Genetics · 1989

3.0/5

Efficient in vitro synthesis of biologically active RNA and RNA hybridization probes from plasmids containing a bacteriophage SP6 promoter

Melton DA, Krieg PA, Rebagliati MR, Maniatis T, Zinn K, Green MR.

Nucleic Acids Res · 1984

3.0/5

Elements of cancer immunity and the cancer-immune set point

Chen DS, Mellman I.

Nature · 2017

2.0/5

A comprehensive set of sequence analysis programs for the VAX

Devereux J, Haeberli P, Smithies O.

Nucleic Acids Res · 1984

2.5/5

An updated definition of stroke for the 21st century: a statement for healthcare professionals from the American Heart Association/American Stroke Association

Sacco RL, Kasner SE, Broderick JP, Caplan LR, Connors JJ, Culebras A, Elkind MS, George MG, Hamdan AD, Higashida RT, Hoh BL, Janis LS, Kase CS, Kleindorfer DO, Lee JM, Moseley ME, Peterson ED, Turan TN, Valderrama AL, Vinters HV, American Heart Association Stroke Council, Council on Cardiovascular Surgery and Anesthesia, Council on Cardiovascular Radiology and Intervention, Council on Cardiovascular and Stroke Nursing, Council on Epidemiology and Prevention, Council on Peripheral Vascular Disease, Council on Nutrition, Physical Activity and Metabolism.

Stroke · 2013

3.0/5

Differential expression analysis for sequence count data

Anders S, Huber W.

Genome Biol · 2010

3.0/5

The species Severe acute respiratory syndrome-related coronavirus: classifying 2019-nCoV and naming it SARS-CoV-2

Coronaviridae Study Group of the International Committee on Taxonomy of Viruses.

Nat Microbiol · 2020

3.3/5

Triple-transgenic model of Alzheimer's disease with plaques and tangles: intracellular Abeta and synaptic dysfunction

Oddo S, Caccamo A, Shepherd JD, Murphy MP, Golde TE, Kayed R, Metherate R, Mattson MP, Akbari Y, LaFerla FM.

Neuron · 2003

2.3/5

Delivery of siRNA to the mouse brain by systemic injection of targeted exosomes

Alvarez-Erviti L, Seow Y, Yin H, Betts C, Lakhal S, Wood MJ.

Nat Biotechnol · 2011

3.3/5

Circulating microRNAs as stable blood-based markers for cancer detection

Mitchell PS, Parkin RK, Kroh EM, Fritz BR, Wyman SK, Pogosova-Agadjanyan EL, Peterson A, Noteboom J, O'Briant KC, Allen A, Lin DW, Urban N, Drescher CW, Knudsen BS, Stirewalt DL, Gentleman R, Vessella RL, Nelson PS, Martin DB, Tewari M.

Proc Natl Acad Sci U S A · 2008

2.0/5

A programmable dual-RNA-guided DNA endonuclease in adaptive bacterial immunity

Jinek M, Chylinski K, Fonfara I, Hauer M, Doudna JA, Charpentier E.

Science · 2012

3.3/5

Apolipoprotein E and Alzheimer disease: risk, mechanisms and therapy

Liu CC, Liu CC, Kanekiyo T, Xu H, Bu G.

Nat Rev Neurol · 2013

4.8/5

Immune checkpoint blockade: a common denominator approach to cancer therapy

Topalian SL, Drake CG, Pardoll DM.

Cancer Cell · 2015

1.8/5

Repurposing CRISPR as an RNA-guided platform for sequence-specific control of gene expression

Qi LS, Larson MH, Gilbert LA, Doudna JA, Weissman JS, Arkin AP, Lim WA.

Cell · 2013

3.0/5

Circ-ZNF609 Is a Circular RNA that Can Be Translated and Functions in Myogenesis

Legnini I, Di Timoteo G, Rossi F, Morlando M, Briganti F, Sthandier O, Fatica A, Santini T, Andronache A, Wade M, Laneve P, Rajewsky N, Bozzoni I.

Mol Cell · 2017

3.3/5

The 2021 WHO Classification of Tumors of the Central Nervous System: a summary

Louis DN, Perry A, Wesseling P, Brat DJ, Cree IA, Figarella-Branger D, Hawkins C, Ng HK, Pfister SM, Reifenberger G, Soffietti R, von Deimling A, Ellison DW.

Neuro Oncol · 2021

3.5/5

DisGeNET: a comprehensive platform integrating information on human disease-associated genes and variants

Piñero J, Bravo À, Queralt-Rosinach N, Gutiérrez-Sacristán A, Deu-Pons J, Centeno E, García-García J, Sanz F, Furlong LI.

Nucleic Acids Res · 2017

2.3/5

Tumor-associated B7-H1 promotes T-cell apoptosis: a potential mechanism of immune evasion

Dong H, Strome SE, Salomao DR, Tamura H, Hirano F, Flies DB, Roche PC, Lu J, Zhu G, Tamada K, Lennon VA, Celis E, Chen L.

Nat Med · 2002

3.8/5

STAR: ultrafast universal RNA-seq aligner

Dobin A, Davis CA, Schlesinger F, Drenkow J, Zaleski C, Jha S, Batut P, Chaisson M, Gingeras TR.

Bioinformatics · 2013

1.8/5

alpha-Synuclein in filamentous inclusions of Lewy bodies from Parkinson's disease and dementia with lewy bodies

Spillantini MG, Crowther RA, Jakes R, Hasegawa M, Goedert M.

Proc Natl Acad Sci U S A · 1998

2.5/5

Imaging brain amyloid in Alzheimer's disease with Pittsburgh Compound-B

Klunk WE, Engler H, Nordberg A, Wang Y, Blomqvist G, Holt DP, Bergström M, Savitcheva I, Huang GF, Estrada S, Ausén B, Debnath ML, Barletta J, Price JC, Sandell J, Lopresti BJ, Wall A, Koivisto P, Antoni G, Mathis CA, Långström B.

Ann Neurol · 2004

4.0/5

Alzheimer's disease

Querfurth HW, LaFerla FM.

N Engl J Med · 2010

2.8/5

A view on drug resistance in cancer

Vasan N, Baselga J, Hyman DM.

Nature · 2019

3.5/5

Sensitivity of revised diagnostic criteria for the behavioural variant of frontotemporal dementia

Rascovsky K, Hodges JR, Knopman D, Mendez MF, Kramer JH, Neuhaus J, van Swieten JC, Seelaar H, Dopper EG, Onyike CU, Hillis AE, Josephs KA, Boeve BF, Kertesz A, Seeley WW, Rankin KP, Johnson JK, Gorno-Tempini ML, Rosen H, Prioleau-Latham CE, Lee A, Kipps CM, Lillo P, Piguet O, Rohrer JD, Rossor MN, Warren JD, Fox NC, Galasko D, Salmon DP, Black SE, Mesulam M, Weintraub S, Dickerson BC, Diehl-Schmid J, Pasquier F, Deramecourt V, Lebert F, Pijnenburg Y, Chow TW, Manes F, Grafman J, Cappa SF, Freedman M, Grossman M, Miller BL.

Brain · 2011

2.5/5

Evolutionary classification of CRISPR-Cas systems: a burst of class 2 and derived variants

Makarova KS, Wolf YI, Iranzo J, Shmakov SA, Alkhnbashi OS, Brouns SJJ, Charpentier E, Cheng D, Haft DH, Horvath P, Moineau S, Mojica FJM, Scott D, Shah SA, Siksnys V, Terns MP, Venclovas Č, White MF, Yakunin AF, Yan W, Zhang F, Garrett RA, Backofen R, van der Oost J, Barrangou R, Koonin EV.

Nat Rev Microbiol · 2020

3.5/5

IL-6 in inflammation, immunity, and disease

Tanaka T, Narazaki M, Kishimoto T.

Cold Spring Harb Perspect Biol · 2014

3.8/5

Non-coding RNA networks in cancer

Anastasiadou E, Jacob LS, Slack FJ.

Nat Rev Cancer · 2018

3.3/5

Intraneuronal beta-amyloid aggregates, neurodegeneration, and neuron loss in transgenic mice with five familial Alzheimer's disease mutations: potential factors in amyloid plaque formation

Oakley H, Cole SL, Logan S, Maus E, Shao P, Craft J, Guillozet-Bongaarts A, Ohno M, Disterhoft J, Van Eldik L, Berry R, Vassar R.

J Neurosci · 2006

1.5/5

Integrated analysis of multimodal single-cell data

Hao Y, Hao S, Andersen-Nissen E, Mauck WM, Zheng S, Butler A, Lee MJ, Wilk AJ, Darby C, Zager M, Hoffman P, Stoeckius M, Papalexi E, Mimitou EP, Jain J, Srivastava A, Stuart T, Fleming LM, Yeung B, Rogers AJ, McElrath JM, Blish CA, Gottardo R, Smibert P, Satija R.

Cell · 2021

3.3/5

Role of the microbiota in immunity and inflammation

Belkaid Y, Hand TW.

Cell · 2014

3.5/5

Correlative memory deficits, Abeta elevation, and amyloid plaques in transgenic mice

Hsiao K, Chapman P, Nilsen S, Eckman C, Harigaya Y, Younkin S, Yang F, Cole G.

Science · 1996

2.8/5

CRISPR-Cas systems for editing, regulating and targeting genomes

Sander JD, Joung JK.

Nat Biotechnol · 2014

3.5/5

RNA-programmed genome editing in human cells

Jinek M, East A, Cheng A, Lin S, Ma E, Doudna J.

Elife · 2013

3.3/5

A scaling normalization method for differential expression analysis of RNA-seq data

Robinson MD, Oshlack A.

Genome Biol · 2010

3.8/5

TREM2 variants in Alzheimer's disease

Guerreiro R, Wojtas A, Bras J, Carrasquillo M, Rogaeva E, Majounie E, Cruchaga C, Sassi C, Kauwe JS, Younkin S, Hazrati L, Collinge J, Pocock J, Lashley T, Williams J, Lambert JC, Amouyel P, Goate A, Rademakers R, Morgan K, Powell J, St George-Hyslop P, Singleton A, Hardy J, Alzheimer Genetic Analysis Group.

N Engl J Med · 2013

3.0/5

Programmable editing of a target base in genomic DNA without double-stranded DNA cleavage

Komor AC, Kim YB, Packer MS, Zuris JA, Liu DR.

Nature · 2016

2.8/5

Caspase-12 mediates endoplasmic-reticulum-specific apoptosis and cytotoxicity by amyloid-beta

Nakagawa T, Zhu H, Morishima N, Li E, Xu J, Yankner BA, Yuan J.

Nature · 2000

4.0/5

Complement and microglia mediate early synapse loss in Alzheimer mouse models

Hong S, Beja-Glasser VF, Nfonoyim BM, Frouin A, Li S, Ramakrishnan S, Merry KM, Shi Q, Rosenthal A, Barres BA, Lemere CA, Selkoe DJ, Stevens B.

Science · 2016

3.8/5

SCENIC: single-cell regulatory network inference and clustering

Aibar S, González-Blas CB, Moerman T, Huynh-Thu VA, Imrichova H, Hulselmans G, Rambow F, Marine JC, Geurts P, Aerts J, van den Oord J, Atak ZK, Wouters J, Aerts S.

Nat Methods · 2017

4.3/5

Cancer immunoediting: integrating immunity's roles in cancer suppression and promotion

Schreiber RD, Old LJ, Smyth MJ.

Science · 2011

2.0/5

Single-cell RNA-seq highlights intratumoral heterogeneity in primary glioblastoma

Patel AP, Tirosh I, Trombetta JJ, Shalek AK, Gillespie SM, Wakimoto H, Cahill DP, Nahed BV, Curry WT, Martuza RL, Louis DN, Rozenblatt-Rosen O, Suvà ML, Regev A, Bernstein BE.

Science · 2014

2.8/5

TopHat: discovering splice junctions with RNA-Seq

Trapnell C, Pachter L, Salzberg SL.

Bioinformatics · 2009

3.0/5

Dissecting the multicellular ecosystem of metastatic melanoma by single-cell RNA-seq

Tirosh I, Izar B, Prakadan SM, Wadsworth MH, Treacy D, Trombetta JJ, Rotem A, Rodman C, Lian C, Murphy G, Fallahi-Sichani M, Dutton-Regester K, Lin JR, Cohen O, Shah P, Lu D, Genshaft AS, Hughes TK, Ziegler CG, Kazer SW, Gaillard A, Kolb KE, Villani AC, Johannessen CM, Andreev AY, Van Allen EM, Bertagnolli M, Sorger PK, Sullivan RJ, Flaherty KT, Frederick DT, Jané-Valbuena J, Yoon CH, Rozenblatt-Rosen O, Shalek AK, Regev A, Garraway LA.

Science · 2016

3.3/5

The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part II. Standardization of the neuropathologic assessment of Alzheimer's disease

Mirra SS, Heyman A, McKeel D, Sumi SM, Crain BJ, Brownlee LM, Vogel FS, Hughes JP, van Belle G, Berg L.

Neurology · 1991

2.8/5

A conceptual framework for research on subjective cognitive decline in preclinical Alzheimer's disease

Jessen F, Amariglio RE, van Boxtel M, Breteler M, Ceccaldi M, Chételat G, Dubois B, Dufouil C, Ellis KA, van der Flier WM, Glodzik L, van Harten AC, de Leon MJ, McHugh P, Mielke MM, Molinuevo JL, Mosconi L, Osorio RS, Perrotin A, Petersen RC, Rabin LA, Rami L, Reisberg B, Rentz DM, Sachdev PS, de la Sayette V, Saykin AJ, Scheltens P, Shulman MB, Slavin MJ, Sperling RA, Stewart R, Uspenskaya O, Vellas B, Visser PJ, Wagner M, Subjective Cognitive Decline Initiative (SCD-I) Working Group.

Alzheimers Dement · 2014

2.3/5